Stocks and Investing Stocks and Investing
Wed, November 8, 2023

Michael Ulz Maintained (CABA) at Buy with Increased Target to $28 on, Nov 8th, 2023


Published on 2024-10-28 07:25:54 - WOPRAI, Michael Ulz
  Print publication without navigation


Michael Ulz of Morgan Stanley, Maintained "Cabaletta Bio, Inc." (CABA) at Buy with Increased Target from $16 to $28 on, Nov 8th, 2023.

Michael has made no other calls on CABA in the last 4 months.



There are 6 other peers that have a rating on CABA. Out of the 6 peers that are also analyzing CABA, 0 agree with Michael's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Michael


  • Joshua Schimmer of "Cantor Fitzgerald" Initiated at Buy and Held Target at $40 on, Tuesday, October 24th, 2023
  • Ben Burnett of "Stifel" Initiated at Strong Buy and Held Target at $31 on, Thursday, October 19th, 2023
  • Douglas Tsao of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $17 on, Wednesday, October 4th, 2023
  • Derek Archila of "Wells Fargo" Maintained at Buy with Increased Target to $39 on, Monday, September 18th, 2023
  • Samantha Semenkow of "Citigroup" Initiated at Strong Buy and Held Target at $22 on, Tuesday, September 5th, 2023
  • Yatin Suneja of "Guggenheim" Reiterated at Strong Buy and Held Target at $34 on, Monday, August 14th, 2023
Contributing Sources